Search clinical trials for: 13 valent Pneumococcal conjugate vaccine

Total 17112 results

GlaxoSmithKline
Affinivax, Inc.

Completed

A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine

Pneumonia, Bacterial | Healthy Volunteers | Pneumococcal Disease

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

Stage IV Lung Adenocarcinoma

United States
Janssen-Cilag Ltd.

Completed

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice (FIRE)

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

France
Pfizer

Completed

Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease

Huntington's Disease

France
Karolinska University Hospital

Completed

Pneumococcal Vaccine in Untreated CLL Patients

Chronic Lymphocytic Leukemia

Sweden
Shire
Takeda Development Center Americas, Inc.

Completed

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (SOAR-HI)

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

United States, Spain, Canada, United Kingdom, France, Germany, Italy
Shandong University

Recruiting

Family-based Screening and Treatment of Helicobacter Pylori：A Real World Study

Helicobacter Pylori | Family

China
Toros University

Not yet recruiting

Metabolic Control Adolescents Type 1 Diabetes

13-18 Year | Diagnosed at Least 6 Months Ago | HbA1C> 7.5 | Being Able to Read and Write
Shenzhen Geno-Immune Medical Institute
The Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children...

Recruiting

Multi-CAR-T Cells Targeting B Cell Lymphomas

B Cell Lymphoma (BCL)

China
Mikhael Petrovich Kostinov
Pfizer

Completed

Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology

Chronic Obstructive Pulmonary Disease | Pneumococcal Infections | Asthma

Russian Federation
Institut National de la Santé Et de la Recherche...

Unknown

Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies (MemO-Epi)

Memory Impairment | Epilepsy, Unspecified, Pharmacologically Resistant

France
INSYS Therapeutics Inc
National Institutes of Health (NIH)

Terminated

Possible New Therapy for Advanced Cancer

Adrenocortical Carcinoma

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria

Hyperoxaluria | Enteric Hyperoxaluria

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

Pneumococcal Infections

Australia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)

Pneumococcal Infections
Memorial Sloan Kettering Cancer Center

Completed

Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing

Breast Cancer

United States
LG Life Sciences

Completed

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Pneumococcal Infections

Korea, Republic of
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
Pfizer

Completed

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Healthy

United States
GPN Vaccines

Recruiting

Extension Safety and Immunogenicity Study of GPNV-001

Pneumococcal Infections

Australia
Jena University Hospital

Completed

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

Pneumococcal Infections

Germany
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)

Pneumococcal Infections
Azienda Sanitaria ULSS 13 Dolo, Mirano

Unknown

Radial Artery Occlusion After Endovascular Procedure

Embolism and Thrombosis of the Radial Artery

Italy
University of California, Los Angeles

Active, not recruiting

Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT)

Infection in Solid Organ Transplant Recipients

United States
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Virus Diseases | Bacterial Infections
Karolinska University Hospital
Pfizer

Completed

PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency (PNEUMOCELL)

IgG Deficiency

Sweden
Memorial Sloan Kettering Cancer Center

Completed

Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer

Rectal Cancer

United States
Aerovance, Inc.
Quintiles, Inc.

Completed

A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)

Allergic Asthma

United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Pneumococcal Infections

United States, Brazil, Colombia, Dominican Republic, Greece, Italy, Panama
Memorial Sloan Kettering Cancer Center
Bayer; State University of New York - Downstate Medical Center; Queens Cancer...

Active, not recruiting

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Metastatic Colorectal Adenocarcinoma

United States
UNC Lineberger Comprehensive Cancer Center

No longer available

Single Subject Neratinib in Bladder Cancer (NRR)

Bladder Cancer

United States
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Pneumococcal Infections | HIV | Pneumococcal Vaccines

United States
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Pneumococcal Infections

United States
GlaxoSmithKline

Completed

A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

Meningococcal

Canada
Affimed GmbH

Completed

A Study to Assess AFM13 in Patients With Hodgkin Lymphoma

Hodgkin Lymphoma

United States, Germany
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

Pneumococcal Infections

United States, Australia, Canada, Chile, New Zealand, Poland, Russian Federation
Pfizer

Completed

Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India

Vaccines

India
Pfizer

Completed

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Healthy Subjects

Japan
GPN Vaccines

Recruiting

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Pneumococcal Infections

Australia
Janssen Research & Development, LLC

Active, not recruiting

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Extraintestinal Pathogenic Escherichia Coli Prevention

United States, France, Belgium, Spain, Netherlands
Merck Sharp & Dohme LLC

Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)

Pneumococcal Infections
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Pneumococcal Infections
Public Health England
Imperial College London; Institute of Child Health

Withdrawn

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants (PINC)

Vaccination | Immunization

United Kingdom
Statens Serum Institut
Hvidovre University Hospital; Herlev Hospital

Completed

Pneumococcal Vaccination of Crohn Patients (PneuVAC)

Crohns Disease

Denmark
EuBiologics Co.,Ltd

Completed

Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

Pneumococcal Disease

Korea, Republic of
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Completed

18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases

Brain Metastases

United States
Stichting Achmea Slachtoffer en Samenleving

Completed

Prophylactic Administration of Vitamin C in Wrist Fractures

RSD (Reflex Sympathetic Dystrophy) | Algodystrophy | CRPS Type I

Netherlands
GlaxoSmithKline

Completed

Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children

Infections, Streptococcal

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)

Pneumococcal Infections

United States, Canada, Denmark, Finland, Israel, Spain
Merck Sharp & Dohme LLC

Completed

A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)

Pneumococcal Infections

Search clinical trials for: 13 valent Pneumococcal conjugate vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations